SamCross

Associate

Brisbane + 61.7.3085.7033

Sam Cross focuses his practice on M&A, equity capital markets, and general corporate matters. He has advised domestic and offshore clients on a broad range of commercial transactions, including business acquisitions and disposals and corporate restructurings.

Sam has assisted boards on various corporate governance issues, including directors' duties, shareholder engagements, and general company secretarial matters in the agribusiness, resources, tourism, and information technology industries.

Prior to joining Jones Day, Sam interned at a Magic Circle law firm in London.

Experience

  • LGIAsuper acquires Suncorp’s superannuation businessJones Day is advising LGIAsuper in the $45 million acquisition of Suncorp’s superannuation business, through the acquisition of Suncorp Portfolio Services Limited (SPSL).
  • Orocobre to merge with Galaxy Resources to form top five global lithium chemicals companyJones Day is advising Orocobre Limited (Orocobre), an ASX and TSX-listed global lithium carbonate supplier with operations in Argentina, on its merger-of-equals with Galaxy Resources Limited (Galaxy), an ASX-listed global lithium company with operations in Australia, Argentina, and Canada, to create a top five global lithium chemicals company (by market capitalization).
  • MAAS Group Holdings Limited (MAAS) completes A$145.6 million IPO on Australian Securities ExchangeJones Day advised MAAS Group Holdings Limited (MAAS) in connection with its A$145.6 million initial public offering on the Australian Securities Exchange (ASX).
  • Eildon Capital acquires Eildon Funds Management Limited from CVC LimitedJones Day advised Eildon Capital Limited in its acquisition of Eildon Funds Management Limited from CVC Limited to internalize its investment management function to form an integrated real estate investment and funds management business.
  • Orocobre raises A$156 million by way of placement and share purchase planJones Day advised Orocobre Limited, a dual ASX and TSX-listed lithium chemicals producer, on a A$156 million capital raising by way of a fully underwritten placement to institutional investors of A$126 million and non-underwritten share purchase plan to shareholders in Australia and New Zealand of up to A$30 million.